Cellular delivery in vivo of siRNA-based therapeutics
A Aigner - Current pharmaceutical design, 2008 - ingentaconnect.com
RNAi interference (RNAi) is an almost standard method for the knockdown of any target
gene of interest in vitro, exploring a naturally occurring catalytic mechanism. Beyond …
gene of interest in vitro, exploring a naturally occurring catalytic mechanism. Beyond …
Tumor-targeted delivery of siRNA by self-assembled nanoparticles
We have developed a self-assembled nanoparticle (NP) that efficiently delivers small
interfering RNA (siRNA) to the tumor by intravenous (IV) administration. The NP was …
interfering RNA (siRNA) to the tumor by intravenous (IV) administration. The NP was …
Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice
N Murata, Y Takashima, K Toyoshima… - Journal of Controlled …, 2008 - Elsevier
The suppression of gene expression of vascular endothelial growth factor (VEGF) which
regulates tumor angiogenesis in vivo and is an important factor in tumor growth represents a …
regulates tumor angiogenesis in vivo and is an important factor in tumor growth represents a …
[引用][C] ЭФФЕКТИВНОСТЬ ПРЕПАРАТА ТЕРАФЛЕКС-АДВАНС В ЛЕЧЕНИИ БОЛЕВОГО СИНДРОМА ПРИ ОСТЕОАРТРОЗЕ КОЛЕННЫХ СУСТАВОВ
ВВ Повороонюк, НИ Дзерович - Научно-практическая ревматология, 2008 - elibrary.ru